Why is Aspira Pathlab falling/rising?

As of 31-Oct, Aspira Pathlab & Diagnostics Ltd is experiencing a decline in its stock price, currently at Rs 60.50, which represents a decrease of Rs 2.5 or 3.97%. The stock has underperformed its sector by 2.7% today and opened with a loss of 2%. It reached an intraday low of Rs 60.47, marking a 4.02% drop. Additionally, the stock is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish trend. The delivery volume has significantly decreased, with a 94.15% drop compared to the 5-day average, suggesting reduced investor participation. There is no information available regarding positive or negative factors that could influence the stock's movement.
In the broader market context, Aspira Pathlab's performance over the past week shows a decline of 5.95%, while the Sensex has only decreased by 0.32%, indicating that the stock is underperforming relative to the benchmark. Over the past month, Aspira Pathlab has seen a significant drop of 11.38%, contrasting with the Sensex's gain of 3.65%. Year-to-date, the stock has a modest increase of 1.68%, but this is still below the Sensex's performance of 7.42%. Overall, the stock's recent decline appears to be influenced by weak trading activity and a lack of positive catalysts, leading to a negative sentiment among investors.